Cyclophosphamide plus cisplatin versus cyclophosphomide, doxorubicin, and cisplatin chemotherapy of ovarian carcinoma: A meta-analysis

G. A. Omura, M. Buyse, S. Marsoni, K. Bertelsen, P. F. Conte, A. Jakobsen, J. Vermorken

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Cyclophosphamide plus cisplatin versus cyclophosphomide, doxorubicin, and cisplatin chemotherapy of ovarian carcinoma: A meta-analysis'. Together they form a unique fingerprint.

Medicine & Life Sciences